Heungkuk Life Insurance Launches 'Dasarang OK335 Simple Health Insurance'

[Asia Economy Reporter Changhwan Lee] Heungkuk Life Insurance announced on the 5th that it has launched the ‘(Non-)Heungkuk Life Multi-Sarang OK335 Simple Health Insurance,’ which reduces the insurance premium burden for policyholders with pre-existing conditions through the 3.3.5 simple screening process.

The 3.3.5 simple screening allows subscription if there is no history of ▲ hospitalization, surgery, or additional examination opinions within the last 3 months ▲ hospitalization or surgery due to illness or accident within the last 3 years ▲ diagnosis, hospitalization, or surgery due to any of the six major diseases within the last 5 years, including cancer, angina, myocardial infarction, heart valve disease, liver cirrhosis, and stroke.

Customers who are healthier than those eligible for the existing simple screening type can receive coverage benefits with premiums approximately 10% lower.

This product guarantees up to 50 million KRW for ‘Car-T anticancer drug approved treatment expenses.’

Additionally, it provides coverage of up to 200,000 KRW and 300,000 KRW respectively for specific anticancer hormone drug approved treatments and thyroid anticancer hormone drug approved treatments, enabling a broad cancer treatment expense coverage plan.

Customers can choose between a renewable product with a 20-year or 30-year maturity and a non-renewable product that provides coverage up to age 100.

This content was produced with the assistance of AI translation services.